-
- Viral targets (pre-clinical)
- Pre-clinical development of antivirals and immune-therapeutics
- Host-Directed Antiviral Therapeutics
- Surveillance & Antiviral Resistance
- Antivirals, Monoclonal Antibodies and Combinations in the clinical setting
- Human challenge studies and new clinical trial designs
Abstract submission deadline: 11.59pm US Pacific time, 10 March 2023
ENQUIRIES: Please email: lidadesouza@isirv.org